SenoRx/Ultrasonix breast biopsy system
This article was originally published in The Gray Sheet
Executive Summary
SenoRx will launch the recently cleared SenoSonix integrated breast biopsy and ultrasound system in January 2008, the firm announces Oct. 17. Aliso Viejo, Calif., firm SenoRx partnered with Canada-based Ultrasonix Medical Corporation to develop the product, which incorporates SenoRx's EnCor vacuum-assisted biopsy technology and Ultrasonix's Sonix ultrasound system, both available independently since 2005. SenoRx will market the device with a focus on physician offices. The firm expects European approval "in the near-term.